Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective
Tim Woelfle, Lucie Bourguignon, Johannes Lorscheider, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e44428-e44428
Open Access | Times Cited: 24
Understanding Depression in People Living with Multiple Sclerosis: A Narrative Review of Recent Literature
Amy B. Sullivan, Bryan E. Davis, Julie K. Kidd, et al.
Neurology and Therapy (2025)
Open Access
A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis
Sofia Sandgren, Lenka Novakova, Anna Nordin, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 12
The relationship between depression and cognitive performance in multiple sclerosis: A meta-analysis
Manuela Altieri, Francesco Cerciello, Antonio Gallo, et al.
The Clinical Neuropsychologist (2023) Vol. 38, Iss. 1, pp. 21-41
Closed Access | Times Cited: 8
Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results
Jeffrey Wilken, Anthony Traboulsee, Flavia Nelson, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 73, pp. 104677-104677
Open Access | Times Cited: 6
The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician’s review
Karolina Kania, Wojciech Ambrosius, Wojciech Kozubski, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis – a real-world evidence study
Jette Lautrup Frederiksen, Luca Massacesi, Helle Hvilsted Nielsen, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 93, pp. 106214-106214
Closed Access | Times Cited: 1
Fatigue and health-related quality of life depend on the disability status and clinical course in RRMS
Henrik Ahvenjärvi, Marja Niiranen, Sakari Simula, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104861-104861
Open Access | Times Cited: 3
Neuromuscular rate of force development discriminates fallers in ambulatory persons with multiple sclerosis - an exploratory study
Nick M Kristensen, Laurits Taul-Madsen, Tobias Gaemelke, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 75, pp. 104758-104758
Open Access | Times Cited: 2
Current advances in the pharmacological prevention and management of cognitive dysfunction in multiple sclerosis
Angelo Bellinvia, Emilio Portaccio, Maria Pia Amato
Expert Opinion on Pharmacotherapy (2022) Vol. 24, Iss. 4, pp. 435-451
Closed Access | Times Cited: 4
Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study
José Eustasio Meca Lallana, Sara Eichau, Bonaventura Casanova, et al.
Journal of Patient-Reported Outcomes (2024) Vol. 8, Iss. 1
Open Access
Comprehensive evaluation of accelerometer-based physical activity in persons with multiple sclerosis – The influence of disability status and its impact on walking capacity
T. Andersen, Åsa Andersén, Morten Riemenschneider, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 93, pp. 106243-106243
Open Access
Psychometric measurement properties and reference values of the six-spot step test, the six-minute walk test, the 25-foot walk test, and the 12-item multiple sclerosis walking scale in people with multiple sclerosis
Anders Guldhammer Skjerbæk, Lars G. Hvid, Finn Boesen, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 94, pp. 106242-106242
Open Access
Page 1

Scroll to top